4//SEC Filing
Lamothe Jeffrey G. 4
Accession 0000950170-25-097267
CIK 0001671584other
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 4:35 PM ET
Size
6.8 KB
Accession
0000950170-25-097267
Insider Transaction Report
Form 4
Lamothe Jeffrey G.
EVP, COO
Transactions
- Exercise/Conversion
Common Stock (post-reverse split May ACTIVE)
2025-07-17+5→ 6 total - Exercise/Conversion
Restricted Stock Unit
2025-07-17−5→ 12 total→ Common Stock (17 underlying)
Footnotes (2)
- [F1]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- [F2]On July 17, 2024, the reporting person was granted 12,825 (17 post-splits) RSUs, vesting in three approximately equal annual installments beginning on July 17, 2025.
Documents
Issuer
Aptevo Therapeutics Inc.
CIK 0001671584
Entity typeother
Related Parties
1- filerCIK 0001679967
Filing Metadata
- Form type
- 4
- Filed
- Jul 20, 8:00 PM ET
- Accepted
- Jul 21, 4:35 PM ET
- Size
- 6.8 KB